340B reforms coming to the congressional table
· mari serebrov
AI Briefing
- • US Congress is set to address 340B prescription drug discount program issues after years of inaction.
- • The 340B program is the second-largest federal drug program, sparking calls for reform.
- • Congressional reform efforts aim to stabilize the program, which has faced criticism and litigation.
Context
The US Congress is taking steps to reform the 340B prescription drug discount program. The program is the second largest federal drug program.
Congressional action on the 340B program matters because it is a significant federal program. Years of hearings and litigation have led to this point.
Advertisement